Objective: To identify factors predictive of smoking cessation after s
uccessful percutaneous coronary revascularization. Material and Method
s: We undertook a case-control study of the smoking status of all pati
ents at Mayo Clinic Rochester from September 1979 through December 199
5 who were smokers at the time of an index percutaneous coronary revas
cularization procedure in the non-periinfarction setting (no myocardia
l infarction within 24 hours), Maximal duration of prospective follow-
up was 16 years, Patients were classified into those who permanently q
uit smoking immediately after the procedure (N = 435; mean follow-up,
5.1 +/- 3.7 years) or those who continued to smoke at some time during
follow-up (N = 734; mean follow-up, 5.3 +/- 3.7 years), Logistics reg
ression models mere formulated to determine independent predictors of
smoking cessation. Results: Predictors of continued smoking were great
er prior cigarette consumption (odds ratio [OR] = 1.009 for each pack-
year; 95% confidence interval [CI] = 1.004 to 1.014) and having one or
more risk factors for coronary artery disease other than cigarette sm
oking (OR = 1.49; 95% CI = 1.15 to 1.93), Older age (OR = 0.98 for eac
h additional year; 95% CI = 0.97 to 0.99) and unstable angina at time
of initial assessment (OR = 0.69; 95% CI = 0.52 to 0.91) were associat
ed with less likelihood of continued smoking. Conclusion: Younger pati
ents with a worse risk profile and greater prior cigarette consumption
were more likely than other patients to continue smoking after percut
aneous coronary revascularization in the non-periinfarction setting, P
atients who had unstable angina were more likely to quit smoking than
those who had stable angina, Despite the proven benefits of smoking ce
ssation after percutaneous coronary revascularization, a substantial p
roportion of smokers (63%) continue to smoke; thus, smoking-cessation
counseling should be addressed in this population.